Skip to main content
Clinical Trials/CTRI/2021/02/031425
CTRI/2021/02/031425Completed未知

A pilot, prospective, interventional study assessing safety and efficacy of HFIM â?? 01 in improving respiratory immunity. - NI

Siddhayu Ayurvedic Research Fdn Pvt Ltd0 sites30 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
未知
Status
Completed
Sponsor
Enrollment
30

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Inclusion Criteria

  • Male and female subjects aged 18 to 60 years (both the ages inclusive)
  • With or without recurrent upper respiratory tract infection or seasonal asthma
  • Ready to provide written informed consent
  • No history of any known allergy with herbal products or any of the ingredients of the test product
  • Willing to come for the followup visits for evaluation

Exclusion Criteria

  • Patients with known uncontrolled diabetes mellitus (DM) HbA1C more than 7.5 hypertension (HT) symptomatic congestive heart failure (CHF) unstable angina pectoris myocardial infarction (MI)
  • Subjects with current medical history of any major illness such as cancer, heart disease, COPD, Asthma etc. in the past
  • Patients participated in another clinical drug trial within 3 months before recruitment in this trial
  • Any other medical condition that in the Investigators opinion would preclude patient participation
  • Pregnant and breast feeding women and women of child bearing age refusing to use contraceptive measures
  • Immunologically compromised individuals
  • Subjects with past history of addiction abuse and rehabilitation

Investigators

Sponsor
Siddhayu Ayurvedic Research Fdn Pvt Ltd

Similar Trials

Evaluate safety and efficacy of HFIM â??... | Clinical Trial